SUBSCRIBE
SUBSCRIBE

Chelsea Weidman Burke

CAR-T Therapy Development on the Rise
CAR-T cells are T-cells that have been engineered to express a receptor (called a chimeric antigen receptor, or CAR) that recognizes a specific type of cancer cell.
June 11, 2019
 · 
8 min read
 · 
Chelsea Weidman Burke
Drug Development
Janssen Hopes to Improve Communication with Clinical Trial Patients Through New Program
“HealthCaring Conversations is a blueprint for having an efficient but empathic conversation with a patient,” said Suzann Johnson, Janssen’s associate director of clinical insights and experience. “We’re taking good conversations and making them great by putting the patient at the center of every conversation.”
June 10, 2019
 · 
7 min read
 · 
Chelsea Weidman Burke
Drug Development
The Next Frontier of CAR-T Therapies: Off-the-Shelf Therapies
While this type of personalized therapy is revolutionizing cancer treatment and healthcare, it has some formidable limitations.
April 1, 2019
 · 
7 min read
 · 
Chelsea Weidman Burke
Does Vaccinating Against Rotavirus Also Protect Against Type 1 Diabetes?
The rotavirus vaccine may be pulling double duty; it not only protects young children against a potentially life-threatening rotavirus infection but may also reduce their likelihood of developing type 1 diabetes.
February 23, 2019
 · 
4 min read
 · 
Chelsea Weidman Burke
World can soon witness a male birth control gel.
Drug Development
Interview: First-of-Its-Kind Male Contraceptive Gel (Male Birth Control Gel)in Phase 2b Clinical Trial
The first trial of male birth control gel to check its safety is underway. If approved, this could be the first male hormonal birth control on the market.
February 15, 2019
 · 
7 min read
 · 
Chelsea Weidman Burke
Drug Development
DNA-Damaged Sperm Identified as New Biological Marker for Repeated Miscarriages
A study published in Clinical Chemistry earlier this month has linked sperm with more DNA damage to repeated miscarriages. Recurring miscarriages, defined as three or more consecutive miscarriages before 20 weeks of pregnancy, occur in 1-2 percent of couples.
January 16, 2019
 · 
5 min read
 · 
Chelsea Weidman Burke
Business
How Automation Will Bring BioPharma Research Into the 21st Century
As technology advances, more of it becomes automated. While some manufacturing industries have long utilized automation throughout their processes and product production, the biopharma industry is comparatively behind the times.
December 28, 2018
 · 
4 min read
 · 
Chelsea Weidman Burke
Drug Development
Deep Dive: Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the Game
Checkpoint inhibitors are only effective against inflamed tumors, called ‘hot’ tumors. Unfortunately, most tumors are ‘cold’ (not inflamed) and hide from the immune system by appearing to be too similar to normal cells.
November 12, 2018
 · 
10 min read
 · 
Chelsea Weidman Burke
Policy
FDA, DHS Strengthen Collaboration Against Medical Device Cybersecurity Threats
The U.S. Food and Drug Administration (FDA) and Department of Homeland Security (DHS) are celebrating National Cybersecurity Awareness Month by announcing a strengthened partnership to buff up medical device cybersecurity, increasing communication and coordination between the two agencies.
October 31, 2018
 · 
4 min read
 · 
Chelsea Weidman Burke
The Importance of Diversity in Clinical Trials (Because Right Now, It’s Lacking)
Although race is thought of as a social concept, ‘there’s growing evidence that, whether for environmental or genetic reasons, drugs may have different effects on different populations.’
October 9, 2018
 · 
6 min read
 · 
Chelsea Weidman Burke
Biotech Beach
Why Does Immunotherapy Cost So Much?
The use of multiple, potentially costly, drugs during combination therapy all contributes to the high costs in oncology. DO you know why does immunotherapy cost so much?
October 3, 2018
 · 
4 min read
 · 
Chelsea Weidman Burke
Drug Development
Promising Early-Stage Results for Novel Malaria Therapeutics
Two antimalarial strategies have been published from Imperial College London in the past month: new compounds that prevent the malaria parasite from infecting mosquitoes and gene-edited mosquitoes that cannot reproduce, leading to population destruction.
October 2, 2018
 · 
4 min read
 · 
Chelsea Weidman Burke
Policy
One Company Owns Almost Half of Marine Gene Sequence Patents: What It Could Mean for Drug Discovery
German chemical company BASF, the world’s largest chemical producer, has registered 47 percent of patented marine organism gene sequences, according to a study published in Science Advances in June.
October 1, 2018
 · 
4 min read
 · 
Chelsea Weidman Burke
Policy
What Is Driving Biopharma Execs Into Politics?
Making the jump from biotech to politics may not seem like a typical career progression. So, what is driving these executives into politics?
September 25, 2018
 · 
3 min read
 · 
Chelsea Weidman Burke
Load More